Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Aug 24, 2026
Revenue (TTM)
$38.09B
+9.5% YoY
Gross margin
71.9%
EPS (latest q)
$6.29
vs $5.60 est · beat
52-wk position
99.7%
-0.1% vs 52w high · +17.5% 1mo
Price (last ~year)
Amgen Inc. (AMGN) reported Q2 2026 revenue of $10.05 billion and net income of $2.38 billion, marking four consecutive quarters of earnings beats. The company maintains a market capitalization of $237.52 billion with 71.9% gross margins and 64.9% year-over-year earnings growth. Shares are trading at $439.33, up 31.5% over the last three months and positioned near the 52-week high.
Valuation
- Market cap
- $237.52B
- P/E
- 27.32
- PEG
- 2.306
- P/B
- 20.32
- P/S
- 6.23
- EV/EBITDA
- 15.94
- Beta
- 0.413
- Analyst target
- $388.48
Quality & returns
- Gross margin
- 71.9%
- Operating margin
- 35.5%
- Profit margin
- 23.0%
- ROE
- 91.5%
- ROA
- 8.7%
Price movement
- Last
- $439.33
- 1-month
- +17.5%
- 3-month
- +31.5%
- RSI (14)
- 82
- vs SMA200
- +26.2%
- 52-wk position
- 99.7% -0.1% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $10.05B | $3.51B | $2.38B | $3.44B |
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
Recent news
- Neutral Biotech ETF Showdown: Why a 251-Stock Basket Is Beating Concentrated Rivals · 2026-08-23
- Neutral Does First-in-Class FOP Drug Approval Transform the Bull Case For Regeneron Pharmaceuticals (REGN)? · 2026-08-23
- Somewhat-Bullish Beutel Goodman & Co Ltd. Sells 128,742 Shares of Amgen Inc. $AMGN · 2026-08-23
- Somewhat-Bullish Amgen Inc. $AMGN Shares Sold by Commerce Bank · 2026-08-23
- Somewhat-Bullish Bank of Nova Scotia Sells 158,139 Shares of Amgen Inc. $AMGN · 2026-08-23
- Neutral ETFs Investing in Amgen Inc. Stocks · 2026-08-23
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)